Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 3,511 | 4,149 | 2,479 | 2,452 | 2,896 |
| Operating Income | -3,511 | -4,149 | -2,479 | -2,452 | -2,896 |
| Other Income | -29 | 95 | 163 | 0 | 0 |
| Pre-tax Income | -3,540 | -4,054 | -2,317 | -2,452 | -2,896 |
| Net Income Continuous | -3,540 | -4,054 | -2,317 | -2,452 | -2,896 |
| Net Income | $-3,540 | $-4,054 | $-2,317 | $-2,452 | $-2,896 |
| EPS Basic Total Ops | -0.32 | -0.36 | -0.21 | -0.24 | -0.55 |
| EPS Basic Continuous Ops | -0.32 | -0.36 | -0.21 | -0.24 | -0.56 |
| EPS Diluted Total Ops | -0.32 | -0.36 | -0.21 | -0.24 | -0.55 |
| EPS Diluted Continuous Ops | -0.32 | -0.36 | -0.21 | -0.24 | -0.56 |
| EBITDA(a) | $-3,369 | $-4,147 | $-2,478 | $-2,451 | $-2,895 |